Early preconditioning
coronary occlusion. Both aminoguanidine and dexamethasone were found to completely block the infarct-limiting Vegh and colleagues in a canine model of pacingeffect of PC [28] . induced arrhythmias showed that the anti-arrhythmic effect of PC was abolished by the NO pathway inhibitor Ngnitro-arginine methyl ester (L-NAME) [20] and methylene 5. Possible mechanisms of action blue, a guanylate cyclase inhibitor [21] . Furthermore, the NO donors glyceryl trinitrate and 3-morpholinoWhat has emerged from the PC field is that a variety of sydnonimine-hydrochloride (SIN-1) have been shown to ligands and their corresponding receptors may act in an mimic the effects of PC in abolishing reperfusion-induced additive fashion to trigger protection. Our current underventricular arrhythmias in the isolated rat heart [22] . These standing of the post-receptor cascade is embraced by the studies above suggest NO protects against ischaemiaDowney hypothesis where by activated receptors couple to reperfusion arrhythmia in the dog. However, using this G proteins leading to the activation of protein kinase C phenomenon as a surrogate for PC is difficult as PC (PKC) via the formation of diacylglycerol [29] . The against ischaemia-reperfusion arrhythmia is not present in complex downstream pathways are currently under inall species e.g. swine . Also the question of whether NO vestigation and are likely to involve modulation of various can protect against ischaemic cell death in early PC kinases including tyrosine and mitogen-activated kinases remains unclear. [30] . Several protein effectors have been described in the Unpublished data from our laboratory in a simulated late phase of PC including heat shock proteins [31] but it is ischaemia model of early PC in rat neonatal cardiocytes becoming increasingly clear that an end effector of PC is suggests that the NO donor s-nitroso-N-acetyl-L,L-penilikely to be the ATP-sensitive potassium channel [32] cillamine (SNAP) given for 90 min prior to lethal hypoxia Circumstantial evidence exists implicating NO and its significantly protects against ischaemic injury. Also, the interactions in the signalling scheme of PC. However, protective effect of PC is blocked by the NO synthase unique properties of the NO-guanylate cyclase-cyclic (NOS) inhibitor Ng-monomethyl-L-arginine (LNMMA). If guanosine 3,5-monophosphate (cGMP) pathway provide a NO is important in early PC then endothelial NO generaparallel hypothesis whereby NO has an independent role in tion in response to ischaemia must have an important role.
cardiac protection. The influence that NO may have in Further experiments are required to further understand the modulating the accepted signalling pathway underlying PC endothelial-myocyte-NO interaction during the early is represented in Fig. 1 with relevent evidence summarised phase of protection. below.
Free radical generation 4. Late preconditioning
Studies of ischaemia / reperfusion injury have high-A delayed increase in NO production has been shown lighted the importance of NO as a free radical donor. following ischaemia / reperfusion which coincides with the Ischaemia / reperfusion generates calcium and NADPH time course of late PC [23] . Subsequently recent research both necessary for NO production together with superoxide has implicated NO as both a trigger and mediator of late anions [33] . NO combines with superoxide to generate PC. Bolli and colleagues in conscious rabbits showed that peroxynitrite which then decomposes to yield the hydroxyl late PC against stunning was inhibited by NOS inhibitors radical [34] and other reactive oxygen species. Interesting- [24] . Of particular interest was the finding that the nonly, oxidative stress has been shown to directly activate selective NOS inhibitor L-nitro-arginine (LNA) given at extracellular signal related kinases in cardiac myocytes day one inhibited PC at day 2 whereas the selective [35] . Also several studies have demonstrated activation of inducible NOS inhibitors aminoguanidine and PKC by oxygen radicals [36] and hydrogen peroxide methylisothiourea given at day 2 inhibited PC at day 3. [37, 38] . This provides a novel hypothesis by which NO This suggests a role for both constitutive cNOS and iNOS derived reactive oxygen species may trigger the pathway in late PC, the expression and importance of which may be leading to PC. Recent data lending further support for a temporally regulated [25] . More recently the same group role of NO-mediated free radical generation in late PC is have reported that the infarct-sparing effect of late PC can provided by Bolli's group who have found that the also be blocked by LNA suggesting that NO synthase as a cardioprotective effects of NO are completely abrogated by mediator of PC against myocardial infarction [26] . Parthe antioxidant mercaptopropionyl glycine, a scavenger of ratt's group have previously implicated iNOS in late PC peroxynitrite and hydroxyl radicals [39] . where the protective effect of pacing against arrhythmias in dogs was abolished by dexamethasone, an inhibitor of 5.2. Lipopolysaccharide iNOS [27] . This is supported by more recent data in a PC model assessing infarct size in anaesthetised rabbits after
The observation that sublethal doses of bacterial endo- toxin (lipopolysaccharide) can increase myocardial resistcritical thiol residues which determine its activity it is not ance to ischaemia and reperfusion was first made in 1989 surprising that NO can regulate this enzyme. Evidence for by Brown et al [40] and subsequent research suggests this a negative regulatory effect of NO on PKC appears in may be an important trigger for delayed protection, other cell systems studied. For example in a B16 although the exact mechanism remains unclear [41] . melanoma cell line NO gas, sodium nitroprusside and Endotoxin is a powerful activator of iNOS [42] fueling SNAP rapidly caused both reversible and irreversible recent interest in NO as the effector. Several preliminary inhibition of PKC predominantly by the inhibition of reports in abstract form have implicated NO in PC phorbol ester binding [48] . Conversely, PKC can modulate experiments using monophosphoryl lipid A (MLA), a the actions of NO. Overexpression of rat PKC with a modified less pyrogenic lipopolysaccharide derivative.
replication-incompetent retroviral vector in rat mesangial MLA causes protection by the induction of iNOS through cells has been shown to increase iNOS expression assessed tyrosine phosphorylation [43] and this effect can be by immunoblotting [49] . However, a counter-regulatory abolished by L-NAME [44] .
role for PKC with cNOS is suggested in a study where the PKC inhibitors staurosporine or chelerythrine caused the 5.3. Adenosine increased expression of cNOS in bovine aortic endothelial cells [50] . Further studies are required to elucidate the Adenosine, produced in response to ischaemia, can exact relationship between NO and myocardial PKC trigger PC in most species and is an important ligand in the isoforms thought to be involved in PC. The possible Downey hypothesis. A relationship with NO must clearly interactions between adenosine, PKC, NOS and NO are exist as adenosine mono-and diphosphate are important summarised in Fig. 2 . activators of the calcium -dependent cNOS [45] . Indeed, in a model of PC against hepatic ischaemia-reperfusion injury adenosine has been shown to stimulate NO pro-5.5. Heat shock protein upregulation duction to protect against hepatocellular injury [46] . Activation of iNOS has also been shown experimentally in Heat shock proteins (HSP) are upregulated in response cultured rat cardiac myocytes where interleukin-1-induced to ischaemic or heat stress and have been implicated as nitrite production is significantly increased by the addition protein effectors in late PC [31] . Evidence is also emerging of adenosine or chloroadenosine. This effect was not that NO can cause cytoprotection by inducing HSP expresattenuated in the presence of a PKC inhibitor [47] .
sion. The NO donor SNAP has been shown to protect cultured rat hepatocytes from tumour necrosis factor-in-5.4. Protein kinase C duced apoptosis by the induction of HSP70 [51] . Preliminary data involving an in vivo rabbit model of SWOP have S-nitrosylation of protein thiols is one of the regulatory shown that NO-induced protection is associated with an cellular mechanisms of nitric oxide [5] . Since PKC has increase in HSP72 expression [52] .
NO-dependent insulin release from pancreatic islet cells [60] and peripheral vascular vasodilatory responses [61, 62] have been found to involve specific K-ATP channels. The finding that NO can potentiate the ATP sensitive K channel current in isolated guinea-pig ventricular cells [63] raises the distinct possibility that NO could modulate mitochondrial K-ATP channels in human myocardium and provides an exciting research challenge for the future.
Modulation of mitochondrial function
How opening of mitochondrial K-ATP channels confers protection is unknown but current hypotheses include (i) the reduction of calcium influx through the calcium through the control of matrix volume. The latter may play an important role in the regulation of mitochondrial Bradykinin released early during ischaemia stimulates metabolism and this subject has been reviewed extensively endothelial cNOS [53] and can mimic PC [11] . The above [65] , but in the context of NO this mechanism may have hypothesis suggests that bradykinin-induced cNOS activaimportant implications. NO has been shown to reversibly tion from the endothelium during PC liberates NO which inhibit cytochrome C oxidase but its oxidised product acts on the myocyte via the guanylate cyclase-cGMP peroxynitrite irreversibly inhibits complexes I-III of the pathway to cause cytoprotection. However, the protective respiratory chain in brain submitochondrial particles [66] . effects of bradykinin can occur independently of NO Whether inhibition is reversible or irreversible depends on perhaps via PKC activation [54] .
the availability of superoxide to form peroxynitirite, the A clear rationale exists as to why cGMP could be presence of glutathione and this in turn determines cell protective in PC. For example NO-induced elevated cGMP viability. can act by (i) reducing the influx of calcium through Mitochondrial dysfunction is a critical component of L-type calcium channels; (ii) stimulating a cyclic GMP ischaemia-reperfusion injury and is characterised by dissisensitive phosphodiesterase with a resultant reduction in pation of the membrane potential, induction of the mitolevels of cyclic adenosine monophosphate (cAMP) [55] .
chondrial permeability transient and ATP depletion. A This together with the known effect of NO in reducing recent study has demonstrated mitochondrial adaptation to myocyte contractility [56] would serve to reduce oxygen hypoxia through a partial and reversible inhibition of consumption and energy demand. Preliminary data has mitochondrial respiration which resulted in the mainteshown elevated cGMP levels during PC by SNAP in nance of cell viability without net ATP depletion [67] . We isolated perfused hearts [57] providing further support for have recently demonstrated reversible inhibition of respirainvolvement of the NO-cGMP pathway.
tion by NO in neonatal rat cardiocytes in culture without dissipation of the membrane potential (unpublished data).
The K ATP channel
This phenomenon, through the reversible modulation of metabolism, may represent, a physiological mechanism by The observation that ATP-sensitive K channel openers which mitochondria metabolically adapt to hypoxia and protect against experimental myocardial ischaemia [58] may provide a plausible hypothesis to the cytoprotection was initially thought to be related to shortening of action conferred by NO. potential duration and a resultant reduced calcium influx. However, subsequent experiments have demonstrated that the mitochondrial K channel plays a greater role than the sarcolemmal channel and may be closer to the end effector 6. Clinical perspective: the nitrate controversy of PC [59] . Exactly how mitochondrial K-ATP channel opening results in protection remains unclear but the end
The principal beneficial effects of NO in reducing result may involve ATP conservation perhaps via modulapreload, augmenting collateral coronary flow and inhibtion of oxidative phosphorylation through the regulation of iting platelet aggregation [42] provide a powerful theoretmitochondrial volume.
ical basis for the use of nitrates in the routine treatment of Some physiological effects of NO are already linked to ischaemic syndromes, myocardial infarction (MI) and the activation of ATP-dependent K channels. For example heart failure. Despite this rationale the routine use of nitrates as cardioprotective agents to reduce mortality If NO can precondition the myocardium then nitrates may remains uncertain.
also have a protective role before routine cardiac surgery. Myocardial infarction: In a small number of MI trials predating the thrombolytic era intravenous nitrates were thought to have beneficial effects on infarct size and 7. Future strategies mortality [68-70] Subsequent meta-analysis of these trials indicated up to a 49% reduction in mortality with the use From our understanding of experimental and clinical of prolonged intravenous nitroglycerin [71, 72] . However, preconditioning and the emerging evidence for the role of the later and larger mega-trials such as ISIS-4 [73] and NO in cardioprotection perhaps the emphasis should now GISSI-3 [74] could not confirm a beneficial effect on be shifted to extensively re-exploring a role for nitrates mortality in contradiction to previously published data.
before myocardial necrosis has occurred. Large properly One major criticism of the ISIS-4 and GISSI-3 mega-trials designed trials in the context of stable and unstable angina was the widespread use of open-label oral nitrates in the are required to answer this question. What is likely to be of placebo and control groups (62% and 57% respectively) paramount importance is the timing of therapy in relation which may have diluted the true effects of nitrates in both to infarction, dose regime and the concept of nitrate studies [75] . Of course the use of intravenous nitrates was tolerance. Indeed, the largest pre-thrombolytic randomised not addressed in these studies and no study has specifically trial of intravenous nitrates following MI by Jugdutt and assessed the potential benefit of nitrate therapy before MI.
Warnica showed that the infarct size-reducing effect of Angina: Despite clear demonstrable effects in relieving nitroglycerin was most marked when therapy was begun symptoms and electrocardiographic changes of ischaemia less than 4 hours from the onset of pain and critically nitrates have not been shown to influence mortality in dependent on dosage [82] . Future therapeutic strategies are stable or unstable angina. The observation that pre-infarclikely to involve the development of more stable NO tion angina may represent a correlate for PC in humans has donors, the adjunctive use of free radical scavengers and been demonstrated in several studies but remains controthe pharmacological use of agents downstream of NO. versial. In one of the largest studies analysing patients in Thus, a cardioprotective role for the selective type-5 cGMP the Thrombolysis in Myocardial Infarction (TIMI) 4 study phosphodiesterase inhibitor sildenafil (Viagra) may yet to [76] the presence of pre-infarction angina reduced the be found? combined end-points of in-hospital death, severe conges-NO is emerging as an important cytoprotective agent tive heart failure or shock from 12% in patients with no and may play a pivotal role in myocardial protection both preceding angina to 4%. As expected the use of oral as a trigger and mediator of PC. The role of nitrates in the anti-anginal medication was higher in the angina group clinical setting needs to be re-addressed in the context of a prior to MI. In particular nitrate usage was 34% in the therapeutic strategy prior to MI before excluding the angina group compared to 14% in the no angina group and possibility of real benefits in terms of infarct size and it is interesting to speculate as to the contribution of mortality. The recent description of a physiologically antecedent nitrate treatment to cardioprotection. relevant murine model of early and late ischaemic PC [83] Heart failure: The beneficial haemodynamic effects of will provide a powerful tool for the future use of genetic nitrates in preload reduction inducing a reduction in engineering in elucidating the cellular mechanisms of pulmonary and left venticular end diastolic pressure are preconditioning and the role of NO. Thus a greater beneficial in heart failure. A recent study of the use of scientific understanding of the basis of NO-induced cytointravenous nitrates in acute severe pulmonary oedema protection against ischaemic injury may help to answer showed a significant reduction in 7 day mortality [77] . No these important clinical questions. study has assessed the sole use of nitrates in chronic heart failure but the V-HeFT I and II trials [78] showed that the combination of isosorbide dinitrate and hydralazine proReferences duced a 38% reduction in mortality at 1 year compared to placebo or prazosin .
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